Сторінки без посилань

Наступні сторінки не містять посилань на інші сторінки цієї вікі.

Нижче показано до 50 результати у діапазоні від #31 до #80.

Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).

31. (80.45 ) and 17 individuals 6 points (19.55 ). 5 sufferers (5.74 ) created liver decompensation for the duration of antiviral therapy.
32. (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
33. (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (five.74 ) developed liver decompensation for the duration of antiviral therapy.
34. (80.45 ) and 17 individuals six points (19.55 ). Five individuals (5.74 ) created liver decompensation for the duration of antiviral therapy.
35. (80.45 ) and 17 patients 6 points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
36. (80.45 ) and 17 patients 6 points (19.55 ). Five individuals (five.74 ) developed liver decompensation in the course of antiviral therapy.
37. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) created liver decompensation during antiviral therapy.
38. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
39. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation in the course of antiviral therapy.
40. (80.45 ) and 17 patients six points (19.55 ). 5 patients (five.74 ) created liver decompensation through antiviral therapy.
41. (80.45 ) and 17 patients six points (19.55 ). 5 sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
42. (80.45 ) and 17 patients six points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
43. (80.45 ) and 17 sufferers 6 points (19.55 ). 5 sufferers (five.74 ) developed liver decompensation during antiviral therapy.
44. (80.45 ) and 17 sufferers 6 points (19.55 ). Five patients (5.74 ) developed liver decompensation during antiviral therapy.
45. (80.45 ) and 17 sufferers 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
46. (A) Stomatal closure in wild kind Col- (white bars) and ahk5-one (black bars) leaves 2.five h soon after exposure to escalating concentrations of H2O2
47. (E) Step three uses the Gamma parameter plane spanned by the shape
48. (F) Estimation of the number of viable cells at 48 and 96 h in P19 cells taken care of with .32 M CsA throughout EB formation
49. (Figure 1D). Infections with strains carrying welldefined mutations identified to exclusively
50. (GenBank accession no. DQ389174), which was reported to have low identity
51. (GenBank accession no. DQ389174), which was reported to possess low identity
52. (N = 37), such as those encoding 13 protein
53. (Table 1). We developed a extremely sensitive search tactic combining key terms
54. (UNCH-A section) and represented by the socalledRhino-SandsofDaxner-H ketal.(2017,thisissue).The correlation
55. (along with the BDFE) of tBu3PhOH.40 The EPR equilibration process supplies
56. (as well as the BDFE) of tBu3PhOH.40 The EPR equilibration method offers
57. (aspect 1 = three.96 and factor 2 = 1.82). The two-factor structure was consistent with our theoretical
58. (mean of 3 set of experiments) in induced nNOS mRNA (column AAV
59. (sd 5 five.3). Age of onset at Wave three was obtained in two techniques
60. ), CKD (N = 261), cardiovascular (N = 578), diabetes (N = 857) and respiratory groups (N = 1156) d
61. ). The very first step is assuming or estimating a discrete selection model
62. ); and by the Intramural Analysis Plan (RMP) on the National Institute
63. ); and by the Intramural Analysis Plan (RMP) with the National Institute
64. ); and by the Intramural Analysis System (RMP) in the National Institute
65. ); and by the Intramural Analysis System (RMP) of your National Institute
66. ); and by the Intramural Analysis System (RMP) on the National Institute
67. ); and by the Intramural Analysis System (RMP) with the National Institute
68. ); and by the Intramural Investigation Plan (RMP) in the National Institute
69. ); and by the Intramural Investigation Plan (RMP) on the National Institute
70. ); and by the Intramural Investigation Plan (RMP) with the National Institute
71. ); and by the Intramural Investigation Program (RMP) in the National Institute
72. ); and by the Intramural Investigation System (RMP) in the National Institute
73. ); and by the Intramural Investigation System (RMP) of your National Institute
74. ); and by the Intramural Investigation System (RMP) with the National Institute
75. ); and by the Intramural Research System (RMP) of your National Institute
76. ); and by the Intramural Study Plan (RMP) with the National Institute
77. ); and by the Intramural Study Program (RMP) in the National Institute
78. ); and by the Intramural Study Program (RMP) of the National Institute
79. ); and by the Intramural Study Program (RMP) of your National Institute
80. ); and by the Intramural Study Program (RMP) with the National Institute

Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).